Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep13 | Adrenal and Neuroendocrine Tumours | ECE2018

Hypothyroidism occurrence during treatment of neuro endocrine tumor

Belazzouz Abderahmen Youssouf , Azzouz Malha , Boudiba Aissa

Introduction: Several treatments may be proposed against neuroendocrine tumors such as targeted therapies (Tyrosine kinase inhibitors: TKI) and somatostatin agonist. Since the first use of TKI in the oncological field, several studies have shown endocrine side effects type dysthyroidie. Several complex pathophysiological mechanisms and variable from one patient to another have been evoked ranging from a simple thyroiditis to complex autoimmune phenomena (cases of Basedow revea...